ESC 365 - Evaluation of LDL cholesterol level in patients with coronary artery disese after cardiac rehabilitation

EAPC Premium Access

Evaluation of LDL cholesterol level in patients with coronary artery disese after cardiac rehabilitation

Session: Poster Session 1 - Lipids

Topic: Lipids

Speaker: Professor N. Mouine (Rabat, MA)

Event: EuroPrevent 2018

Congress Presentation

Add to my library

About the speaker

Professor Najat Mouine

Military Hospital Mohammed V, Rabat (Morocco)

5 presentations

1 follower

9 more presentations in this session

Lipids - Poster discussant:

Improvement of lipid profile post cardiac rehabilitation according to the patient's level of risk in a tertiary hospital

Speaker: Doctor A. Chauca Tapia (Girona, ES)

Efficacy of the PCSK9 inhibitors evolocumab/alirozumab in the reduction of LDL and Lp (a) in patients with familial hypercholesterolemia/manifest atherosclerosis in a real world setting

Speaker: Mr M. Poudel (Bielefeld, DE)

Anti-PCSK9 in everyday clinical practice

Speaker: Doctor R. Cadenas Chamorro (Madrid, ES)

Safety aspects and side effects of the novel lipid-lowering PCSK9 inhibitors evolocumab /alirozumab in atherosclerotic patients with familial hypercholesterolemia under lipid apheresis

Speaker: Mr M. Poudel (Bielefeld, DE)

Access the full session

Poster Session 1 - Lipids

Speakers: Professor N. Mouine, Doctor A. Chauca Tapia, Mr M. Poudel, Doctor R. Cadenas Chamorro, Mr M. Poudel

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources